179530 — ADBiotech Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩56bn
- KR₩63bn
- KR₩13bn
Annual cashflow statement for ADBiotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2,664 | 2,696 | -5,432 | -8,987 | -3,329 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1,425 | -7,068 | 457 | 5,272 | -152 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,574 | -4,946 | 4,156 | -1,402 | 1,205 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2,162 | -8,592 | 315 | -4,092 | -1,319 |
| Capital Expenditures | -3,561 | -727 | -290 | -193 | -378 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -963 | -1,472 | 2,697 | 1,435 | -25,627 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4,524 | -2,199 | 2,407 | 1,241 | -26,004 |
| Financing Cash Flow Items | -12.8 | -397 | 0 | -8.83 | -183 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5,433 | 10,794 | -885 | 484 | 30,620 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,243 | -16.2 | 1,836 | -2,376 | 3,275 |